No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 8.330
- -0.230-2.69%
Close Dec 24 13:00 ET
- 8.270
- -0.060-0.72%
Post 17:01 ET
1.31BMarket Cap-7.00P/E (TTM)
8.555High8.280Low487.85KVolume8.530Open8.560Pre Close4.08MTurnover0.41%Turnover RatioLossP/E (Static)157.22MShares11.77552wk High3.72P/B1.00BFloat Cap3.76052wk Low--Dividend TTM120.14MShs Float44.190Historical High--Div YieldTTM3.21%Amplitude1.995Historical Low8.372Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Investors Might Be Losing Patience for Ocular Therapeutix's (NASDAQ:OCUL) Increasing Losses, as Stock Sheds 12% Over the Past Week
Possible Bearish Signals With Ocular Therapeutix Insiders Disposing Stock
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Ocular Therapeutix, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference in January 2025
Piper Sandler Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Raises Target Price to $21
Heat List
US
Overall
Symbol
Price
% Chg
No Data